ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PHAR Pharming Group NV

8.31
-0.34 (-3.93%)
28 Mar 2025 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Pharming Group NV NASDAQ:PHAR NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.34 -3.93% 8.31 4.31 9.87 8.85 8.29 8.64 5,632 20:02:00

Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023

26/04/2023 7:00am

PR Newswire (US)


Pharming Group NV (NASDAQ:PHAR)
Historical Stock Chart


From Mar 2023 to Mar 2025

Click Here for more Pharming Group NV Charts.

LEIDEN, Netherlands, April 26, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces that Pharming's Chief Executive Officer, Sijmen de Vries will attend the H.C. Wainwright BioConnect Investor Conference 2023 on May 2, 2023 in New York and will take part in a fireside chat at 11:00 ET/17:00 CEST.

Pharming Group Logo

Pharming's CEO will be available for one-to-one investor meetings during the conference.

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your H.C. Wainwright representative, or send an email to Pharming's Investor Relations team to investor@pharming.com.

About Pharming Group N.V.

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, The Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696

Heather Robertson, Investor Relations & Corporate Communications Manager
E: investor@pharming.com 

FTI Consulting, London, UK Victoria Foster Mitchell/Alex Shaw/Amy Byrne T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands Leon Melens T: +31 6 53 81 64 27 E: pharming@lifespring.nl

Logo: https://mma.prnewswire.com/media/2003587/4004079/Pharming_Group_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pharming-to-attend-the-hc-wainwright-bioconnect-investor-conference-2023-301807076.html

Copyright 2023 PR Newswire

1 Year Pharming Group NV Chart

1 Year Pharming Group NV Chart

1 Month Pharming Group NV Chart

1 Month Pharming Group NV Chart